• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

放射治疗与免疫检查点阻断联合作用增强了小鼠模型中免疫原性差的胰腺癌中的 T 细胞激活。

Radiation combines with immune checkpoint blockade to enhance T cell priming in a murine model of poorly immunogenic pancreatic cancer.

机构信息

Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.

Department of Gastroenterology, Massachusetts General Hospital, Boston, MA 02215, USA.

出版信息

Open Biol. 2021 Nov;11(11):210245. doi: 10.1098/rsob.210245. Epub 2021 Nov 17.

DOI:10.1098/rsob.210245
PMID:34784792
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8595997/
Abstract

Radiation has been a pillar of cancer therapy for decades. The effects of radiation on the anti-tumour immune response are variable across studies and have not been explicitly defined in poorly immunogenic tumour types. Here, we employed combination checkpoint blockade immunotherapy with stereotactic body radiation therapy and examined the effect on tumour growth and immune infiltrates in subcutaneous and orthotopic mouse models of pancreatic cancer. Although immune checkpoint blockade and radiation were ineffective alone, their combination produced a modest growth delay in both irradiated and non-irradiated tumours that corresponded with significant increases in CD8+ T cells, CD4+ T cells and tumour-specific T cells as identified by IFNγ ELISpot. We conclude that radiation enhances priming of tumour-specific T cells in poorly immunogenic tumours and that the frequency of these T cells can be further increased by combination with immune checkpoint blockade.

摘要

几十年来,辐射一直是癌症治疗的基石。然而,辐射对抗肿瘤免疫反应的影响在不同的研究中存在差异,在免疫原性差的肿瘤类型中尚未明确界定。在这里,我们采用立体定向体部放射治疗联合联合检查点封锁免疫疗法,并在胰腺癌的皮下和原位小鼠模型中研究其对肿瘤生长和免疫浸润的影响。虽然免疫检查点阻断和辐射单独使用无效,但它们的联合治疗在辐照和未辐照肿瘤中均产生了适度的生长延迟,这与 CD8+T 细胞、CD4+T 细胞和 IFNγ ELISpot 鉴定的肿瘤特异性 T 细胞的显著增加相对应。我们得出结论,辐射增强了免疫原性差的肿瘤中肿瘤特异性 T 细胞的启动,并且通过与免疫检查点阻断联合使用,可以进一步增加这些 T 细胞的频率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63a5/8595997/0e4ec33e3ff5/rsob210245f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63a5/8595997/dcf0dfb9b498/rsob210245f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63a5/8595997/26ec6ecbcbc4/rsob210245f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63a5/8595997/d577722e5100/rsob210245f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63a5/8595997/0e4ec33e3ff5/rsob210245f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63a5/8595997/dcf0dfb9b498/rsob210245f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63a5/8595997/26ec6ecbcbc4/rsob210245f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63a5/8595997/d577722e5100/rsob210245f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63a5/8595997/0e4ec33e3ff5/rsob210245f04.jpg

相似文献

1
Radiation combines with immune checkpoint blockade to enhance T cell priming in a murine model of poorly immunogenic pancreatic cancer.放射治疗与免疫检查点阻断联合作用增强了小鼠模型中免疫原性差的胰腺癌中的 T 细胞激活。
Open Biol. 2021 Nov;11(11):210245. doi: 10.1098/rsob.210245. Epub 2021 Nov 17.
2
PI3Kγδ inhibitor plus radiation enhances the antitumour immune effect of PD-1 blockade in syngenic murine breast cancer and humanised patient-derived xenograft model.PI3Kγδ 抑制剂联合放疗增强 PD-1 阻断在同种小鼠乳腺癌和人源化患者来源异种移植模型中的抗肿瘤免疫效应。
Eur J Cancer. 2021 Nov;157:450-463. doi: 10.1016/j.ejca.2021.08.029. Epub 2021 Oct 1.
3
Sequence of αPD-1 relative to local tumor irradiation determines the induction of abscopal antitumor immune responses.αPD-1相对于局部肿瘤照射的顺序决定了远隔效应抗肿瘤免疫反应的诱导。
Sci Immunol. 2021 Apr 9;6(58). doi: 10.1126/sciimmunol.abg0117.
4
In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis.光动力疗法联合 rho 激酶抑制诱导的原位免疫清除增强免疫检查点阻断反应,引发针对眼内黑色素瘤及其转移的系统性抗肿瘤免疫。
J Immunother Cancer. 2021 Jan;9(1). doi: 10.1136/jitc-2020-001481.
5
Combination of vasculature targeting, hypofractionated radiotherapy, and immune checkpoint inhibitor elicits potent antitumor immune response and blocks tumor progression.联合血管靶向、低分割放疗和免疫检查点抑制剂可引发强烈的抗肿瘤免疫反应并阻断肿瘤进展。
J Immunother Cancer. 2021 Feb;9(2). doi: 10.1136/jitc-2020-001636.
6
Ablative Radiotherapy Reprograms the Tumor Microenvironment of a Pancreatic Tumor in Favoring the Immune Checkpoint Blockade Therapy.消融放疗重编程胰腺肿瘤微环境有利于免疫检查点阻断治疗。
Int J Mol Sci. 2021 Feb 19;22(4):2091. doi: 10.3390/ijms22042091.
7
CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer.CXCL13 塑造免疫活性肿瘤微环境,并增强 PD-1 检查点阻断在高级别浆液性卵巢癌中的疗效。
J Immunother Cancer. 2021 Jan;9(1). doi: 10.1136/jitc-2020-001136.
8
CD5 blockade, a novel immune checkpoint inhibitor, enhances T cell anti-tumour immunity and delays tumour growth in mice harbouring poorly immunogenic 4T1 breast tumour homografts.CD5 阻断,一种新型免疫检查点抑制剂,增强了携带免疫原性差的 4T1 乳腺癌同种移植物的小鼠的 T 细胞抗肿瘤免疫,并延缓了肿瘤生长。
Front Immunol. 2024 Feb 29;15:1256766. doi: 10.3389/fimmu.2024.1256766. eCollection 2024.
9
A systemically deliverable Vaccinia virus with increased capacity for intertumoral and intratumoral spread effectively treats pancreatic cancer.一种系统性递呈的、具有增强的肿瘤间和肿瘤内传播能力的牛痘病毒能够有效治疗胰腺癌。
J Immunother Cancer. 2021 Jan;9(1). doi: 10.1136/jitc-2020-001624.
10
CDK4/6 inhibition promotes immune infiltration in ovarian cancer and synergizes with PD-1 blockade in a B cell-dependent manner.CDK4/6 抑制促进卵巢癌中的免疫浸润,并以 B 细胞依赖的方式与 PD-1 阻断协同作用。
Theranostics. 2020 Aug 25;10(23):10619-10633. doi: 10.7150/thno.44871. eCollection 2020.

引用本文的文献

1
De novo pyrimidine biosynthesis inhibition synergizes with BCL-X targeting in pancreatic cancer.从头嘧啶生物合成抑制与胰腺癌中靶向BCL-X协同作用。
Nat Commun. 2025 Jul 30;16(1):6987. doi: 10.1038/s41467-025-61242-x.
2
Leveraging radiotherapy to improve immunotherapy outcomes: rationale, progress and research priorities.利用放射疗法改善免疫治疗效果:原理、进展与研究重点
Clin Transl Immunology. 2025 Apr 8;14(4):e70030. doi: 10.1002/cti2.70030. eCollection 2025.
3
Basic helix-loop-helix ARNT like 1 regulates the function of immune cells and participates in the development of immune-related diseases.

本文引用的文献

1
Cancer Immunotherapy: Beyond Checkpoint Blockade.癌症免疫疗法:超越检查点阻断
Annu Rev Cancer Biol. 2019 Mar;3:55-75. doi: 10.1146/annurev-cancerbio-030518-055552. Epub 2018 Nov 7.
2
Special Review: The future of Immunotherapy.专题综述:免疫疗法的未来。
Immunother Adv. 2020 Nov 25;1(1):ltaa005. doi: 10.1093/immadv/ltaa005. eCollection 2021 Jan.
3
Type 2 immunity is maintained during cancer-associated adipose tissue wasting.在癌症相关的脂肪组织消耗过程中,2型免疫得以维持。
碱性螺旋-环-螺旋ARNT样蛋白1调节免疫细胞的功能并参与免疫相关疾病的发生发展。
Burns Trauma. 2025 Jan 18;13:tkae075. doi: 10.1093/burnst/tkae075. eCollection 2025.
4
Consensus, debate, and prospective on pancreatic cancer treatments.胰腺癌治疗的共识、争议与展望。
J Hematol Oncol. 2024 Oct 10;17(1):92. doi: 10.1186/s13045-024-01613-x.
5
Cytosolic nucleic acid sensors and interferon beta-1 activation drive radiation-induced anti-tumour immune effects in human pancreatic cancer cells.细胞质核酸传感器和干扰素 β-1 的激活可促进人胰腺癌细胞的放射抗肿瘤免疫效应。
Front Immunol. 2024 Sep 20;15:1286942. doi: 10.3389/fimmu.2024.1286942. eCollection 2024.
6
Neoadjuvant radioimmunotherapy in pancreatic cancer enhances effector T cell infiltration and shortens their distances to tumor cells.新辅助放免治疗胰腺癌增强效应 T 细胞浸润并缩短其与肿瘤细胞的距离。
Sci Adv. 2024 Feb 9;10(6):eadk1827. doi: 10.1126/sciadv.adk1827. Epub 2024 Feb 7.
7
Multicenter randomized controlled trial of neoadjuvant chemoradiotherapy alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic adenocarcinoma.多中心随机对照临床试验:新辅助放化疗联合或不联合帕博利珠单抗治疗可切除或交界可切除胰腺腺癌。
J Immunother Cancer. 2023 Dec 1;11(12):e007586. doi: 10.1136/jitc-2023-007586.
8
DGKα/ζ inhibition lowers the TCR affinity threshold and potentiates antitumor immunity.DGKα/ζ 抑制降低 TCR 亲和力阈值并增强抗肿瘤免疫。
Sci Adv. 2023 Nov 24;9(47):eadk1853. doi: 10.1126/sciadv.adk1853.
9
PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with Pancreatic Cancer.PD-1 阻断诱导胰腺癌细胞中 NF-κB 信号特征的非生产性 T 细胞反应的重新激活。
Clin Cancer Res. 2024 Feb 1;30(3):542-553. doi: 10.1158/1078-0432.CCR-23-1444.
10
Transforming Growth Factor-β Blockade in Pancreatic Cancer Enhances Sensitivity to Combination Chemotherapy.转化生长因子-β 阻断在胰腺癌中的应用增强了联合化疗的敏感性。
Gastroenterology. 2023 Oct;165(4):874-890.e10. doi: 10.1053/j.gastro.2023.05.038. Epub 2023 May 30.
Immunother Adv. 2021 Jun 2;1(1):ltab011. doi: 10.1093/immadv/ltab011. eCollection 2021 Jan.
4
Leukocyte Heterogeneity in Pancreatic Ductal Adenocarcinoma: Phenotypic and Spatial Features Associated with Clinical Outcome.胰腺导管腺癌中的白细胞异质性:与临床结局相关的表型和空间特征。
Cancer Discov. 2021 Aug;11(8):2014-2031. doi: 10.1158/2159-8290.CD-20-0841. Epub 2021 Mar 16.
5
CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study.CD40 激动性单克隆抗体 APX005M(替戈利木单抗)联合化疗,联合或不联合纳武利尤单抗,用于治疗转移性胰腺导管腺癌:一项开放标签、多中心、1b 期研究。
Lancet Oncol. 2021 Jan;22(1):118-131. doi: 10.1016/S1470-2045(20)30532-5.
6
Composition, Spatial Characteristics, and Prognostic Significance of Myeloid Cell Infiltration in Pancreatic Cancer.胰腺癌中髓系细胞浸润的组成、空间特征和预后意义。
Clin Cancer Res. 2021 Feb 15;27(4):1069-1081. doi: 10.1158/1078-0432.CCR-20-3141. Epub 2020 Dec 1.
7
Tumor-Promoting Ly-6G SiglecF Cells Are Mature and Long-Lived Neutrophils.促瘤 Ly-6G SiglecF 细胞是成熟且长寿的中性粒细胞。
Cell Rep. 2020 Sep 22;32(12):108164. doi: 10.1016/j.celrep.2020.108164.
8
Interrogating the immune-modulating roles of radiation therapy for a rational combination with immune-checkpoint inhibitors in treating pancreatic cancer.探讨放射治疗的免疫调节作用,以实现与免疫检查点抑制剂在治疗胰腺癌方面的合理联合。
J Immunother Cancer. 2020 Jul;8(2). doi: 10.1136/jitc-2019-000351.
9
Dendritic Cell Maturation Defines Immunological Responsiveness of Tumors to Radiation Therapy.树突状细胞成熟定义了肿瘤对放射治疗的免疫反应性。
J Immunol. 2020 Jun 15;204(12):3416-3424. doi: 10.4049/jimmunol.2000194. Epub 2020 Apr 27.
10
Sufficiency of CD40 activation and immune checkpoint blockade for T cell priming and tumor immunity.CD40 激活和免疫检查点阻断对 T 细胞启动和肿瘤免疫的充分性。
Proc Natl Acad Sci U S A. 2020 Apr 7;117(14):8022-8031. doi: 10.1073/pnas.1918971117. Epub 2020 Mar 25.